Joshua Lev, co-CEO, president and CFO of electroCore (NASDAQ:ECOR), said the commercial-stage bioelectronic health and wellness company is seeking to broaden its federal-market presence, expand product indications and reach adjusted EBITDA profitability in the second half of 2027.
Speaking at an in